HLB Co., Ltd.
028300
Rank in Stocks
#4107
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Share Price
$29.77
Market Cap
$3.96B
Change (1 day)
0.23%
Change (1 year)
-6.94%
Country
KR
Trade HLB Co., Ltd. (028300)
Category
Healthcare
Earnings for HLB Co., Ltd. (028300)
Earnings in Jun 2026 TTM: $-160.32M
According to HLB Co., Ltd. latest financial reports the company's current earnings are $-160.32M. In 2023 the company made an earning of $-164.38M, a decrease compared to its 2022 earnings that were of $-62.61M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for HLB Co., Ltd. from 2012 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-160.32M | 115.74% |
| 2024 | $-74.31M | -54.79% |
| 2023 | $-164.38M | 162.55% |
| 2022 | $-62.61M | -27.09% |
| 2021 | $-85.87M | 12.36% |
| 2020 | $-76.43M | 43.17% |
| 2019 | $-53.38M | -540.23% |
| 2018 | $12.13M | -138.75% |
| 2017 | $-31.29M | 69.49% |
| 2016 | $-18.46M | -310.93% |
| 2015 | $8.75M | -632.68% |
| 2014 | $-1.64M | -80.80% |
| 2013 | $-8.56M | 40.17% |
| 2012 | $-6.11M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $5.27B | -3,390.24% |
US
|
|
| $-3.09B | 1,825.53% |
US
|
|
| $-4.02B | 2,405.12% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -1,316.72% |
NL
|
